Pitcairn’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,853
| Closed | -$228K | – | 714 |
|
|
2024
Q4 | $228K | Sell |
4,853
-38
| -0.8% | -$1.79K | 0.01% | 653 |
|
|
2024
Q3 | $258K | Sell |
4,891
-755
| -13% | -$39.9K | 0.02% | 631 |
|
|
2024
Q2 | $306K | Buy |
5,646
+521
| +10% | +$28.2K | 0.02% | 582 |
|
|
2024
Q1 | $359K | Hold |
5,125
| – | – | 0.02% | 526 |
|
|
2023
Q4 | $428K | Buy |
+5,125
| New | +$428K | 0.03% | 445 |
|
|
2023
Q1 | – | Sell |
-5,424
| Closed | -$249K | – | 605 |
|
|
2022
Q4 | $249K | Sell |
5,424
-218
| -4% | -$9.99K | 0.02% | 512 |
|
|
2022
Q3 | $273K | Buy |
5,642
+181
| +3% | +$8.76K | 0.03% | 460 |
|
|
2022
Q2 | $215K | Buy |
+5,461
| New | +$215K | 0.02% | 541 |
|